Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 52409-22-0 | MDL No. : | MFCD00013310 |
Formula : | C51H42O3Pd2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | - |
M.W : | 915.72 | Pubchem ID : | - |
Synonyms : |
|
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280 | UN#: | N/A |
Hazard Statements: | H302-H312-H332 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With caesium carbonate; In 1,4-dioxane; water; | Example 2 1,3,6,8-Tetrakis-(2,4-bis-trifluoromethyl-phenyl)-pyrene 3.95 g (0.0116 mol) of 1,3,6,8-tetrachloro-pyrene, 15.0 g (0.0582 mol) of <strong>[153254-09-2]2,4-bis(trifluoromethyl)phenylboronic acid</strong>, 1.33 g (0.00145 mol) of tris(dibenzylideneacetone) dipalladium (0), 0.64 g (0.00276 mol) of di-tert-butyl-trimethylsilylmethyl-phosphane, 18.95 g (0.0582 mol) of cesium carbonate and 100 ml of dioxane were stirred at room temperature for 24 hours. The resultant mixture was poured into 200 ml of water and extracted twice with 200 ml of methylene chloride. The organic phase was dried over magnesium sulfate overnight and filtered. The solvent was removed on a roto-evaporator and the residue was purified by chromatography on silica gel with petroleum ether/ethyl ether (10/0.5) as eluent. Yield of 1,3,6,8-tetrakis-(2,4-bis-trifluoromethyl-phenyl)-pyrene: 1.08 g (8.85%) as a white solid with m.p. 290.00 C. 1H NMR (CDCl3) 7.45-8.30 (multiplets, 18H, arom-H). 19F NMR (CDCl3) -59.16, -63.27. The structure was confirmed by X-ray analysis. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With sodium t-butanolate; In diethyl ether; toluene; | EXAMPLE 92 (RR,SS)-3-(2-methoxyphenyl)-2-methyl-3-(1-naphthyl)-2-({4-[3-(trifluoromethoxy)phenyl]piperazin-1-yl}carbonyl)propanenitrile (RR,SS)-3-(2-methoxyphenyl)-2-methyl-3-(1-naphthyl)-2-(piperazin-1-ylcarbonyl)propanenitrile (377 mg, 0.913 mmol), meta-trifluoromethoxy bromobenzene (200 mg, 0.830 mmol), sodium tert-butoxide (111 mg, 1.16 mmol), tris(dibenzylideneacetone) dipalladium (0) (22.8 mg, 0.025 mmol), racemic BINAP (31 mg, 0.05 mmol), and toluene (3 mL) were combined in a Carius tube, vacuum degassed, placed under an argon atmosphere, sealed and heated to 80 C. overnight. The reaction was cooled, taken up in diethyl ether, filtered, washed with water, saturated aqueous sodium bicarbonate, brine, dried over MgSO4, filtered, evaporated, and purified on slica gel (10% hexanes/CH2Cl2) to yield 255 mg of the title compound as a white powder. 1H NMR 500 MHz (DMSO-D6): delta 7.97 (d, 1H, J=7.18 Hz), 7.88 (m, 1H), 7.84 (m, 1H), 7.78 (d, 1H, J=8.25 Hz), 7.52 (t, 1H, J=7.48 Hz), 7.41 (m, 2H), 7.30 (t, 1H, J=8.25 Hz), 7.23 (td, 1H, J=7.79 Hz, 1.68 Hz), 7.12 (m, 2H), 6.91 (dd, 1H, J=8.40 Hz, 1.68 Hz), 6.79 (m, 2H), 6.72 (d, 1H, J=8.09 Hz), 6.01 (s, 1H), 4.01 (s, 3H), 3.68 (bs, 4H0, 3.16 (bs, 4H) 1.63 (s, 3H) MS (ESI) m/z 574 ([M+H]+); Anal. calcd for C33H30F3N3O3. 0.35 C6H14: C, 69.82; H, 5.83; N, 6.96. Found: C, 69.81 H, 5.91; N, 6.74. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
17.5% | With potassium carbonate; triphenylphosphine; In ethanol; N,N-dimethyl acetamide; water; | [7-(2-Fluoro-6-methoxy-phenyl)-5-methyl-benzo[1,2,4]triazin-3-yl]-phenyl-amine To a solution of (7-Bromo-5-methyl-benzo[1,2,4]triazin-3-yl)-phenyl-amine (10 mg, 0.032 mmol) dissolved in 2 ml N,N-Dimethylacetamide in a 20 ml vial, 2-Fluoro-6-methoxy-phenylboronic acid (22 mg, 0.128 mmol) dissolved in 1 ml ethanol and potassium carbonate (6.4 mg, 0.06 mmol) dissolved in 1 ml water were added. Triphenylphosphine (1 mg, 0.0038 mmol) and tris(dibenzylideneacetone) dipalladium (0) (1 mg, 1.09 mmol) were added to the mixture. The mixture was reflux overnight. The crude product was filtered and purified by preparative HPLC. 2 mg [7-(2-Fluoro-6-methoxy-phenyl)-5-methyl-benzo[1,2,4]triazin-3-yl]-phenyl-amine was isolated. Yield: 17.5%; ESI-MS: [M+H]+, 361; 1H NMR (CDCl3): delta 2.73 (s, 3H), 3.83 (s, 3H), 6.83-6.86 (m, 2H), 7.14 (m, 1H), 7.34 (m, 1H), 7.45 (m, 2H), 7.75 (s, 1H), 7.92 (m, 2H), 8.24 (s, 1H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
47% | With triethylamine; In ethyl acetate; N,N-dimethyl-formamide; | (1S)-{1-(1H-Indol-3-ylmethyl)-2-[5-(3-phenyl-isoquinolin-6-yl)-pyridin-3-yloxy]-ethyl}-carbamic Acid Tert-Butyl Ester To a solution of Example 80E (150 mg, 0.28 mmol), (1,1,1-tributylstannyl)benzene (137 mg, 0.57 mmol), tris(dibenzylideneacetone)-dipalladium (27 mg, 0.028 mmol) and 2-dicyclohexylphosphino-2'-dimethylamino-1,1'-biphenyl (22 mg, 0.057 mmol) in dry DMF (10 ml) triethyl amine was added under N2. The resulting solution was stirred 3 hours at 100 C. The reaction solution was partitioned between ethylacetate and water. The organic layer was washed (brine), dried (Na2SO4), filtered and concentrated under vacumm. Purification on silica gel with 60% ethyl acetate/hexane to provide the title compound (70 mg, 47%). MS (DCI/NH3) m/e 571 (M+1)+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
30% | In 1,2-dimethoxyethane; | EXAMPLE 52 1-{3- [2-(4-Chlorophenyl)-5-(2-Furanyl)-1-Methyl-1H-Indol-3-yl]-1-Oxopropyl}-4-(Phenylmethyl)-4-Piperidinol 2-Furanylboronic acid (40 mg, 0.36 mmol) and aqueous sodium carbonate (2M, 1 mL) were added to a solution of 1-{3-[5-bromo-2-(4-chlorophenyl)-1-methyl-1H-indol-3-yl]-1-oxopropyl}-4-(phenylmethyl)-4-piperidinol (Example 49, 100 mg, 0.18 mmol) in 1,2-dimethoxyethane (10 mL) and the mixture was degassed. Tris(dibenzylideneacetone) dipalladium(0) (66 mg) and tris(2-furanyl)phosphine (2 mg) were added and the mixture was degassed, then heated to 75 C. overnight. The mixture was cooled and poured into aqueous sodium hydrogen carbonate (saturated, 50 mL) and extracted with ethyl acetate (4*25 mL). The combined organic fractions were washed with brine, dried (MgSO4) and the solvent was evaporated under reduced pressure. The residue was purified by medium pressure liquid chromatography on silica gel, eluding with ethyl acetate: isohexane (1:1), to give the title compound (30 mg, 30%). 1H NMR (360 MHz, CDCl3) delta7.95 (1H, d, J 1.7 Hz), 7.61 (1H, dd, J 1.6, 8.3 Hz), 7.49-7.47 (3H, m), 7.34-7.26 (6H, m), 7.12 (2H, dd, J 1.6, 8.3 Hz), 6.63 (1H, d, J 3.2 Hz), 4.34 (1H, br d, J 12.6 Hz), 3.57 (3H, s), 3.37 (1H, br d, J 10.5 Hz), 3.18 (1H, dt, Jt 11.3, Jd 1.5 Hz), 3.10-3.04 (2H, m), 2.90-2.82 (1H, m), 2.63 (2H, s), 2.58-2.52 (2H, m), 1.47-1.42 (2H, m), 1.34 (1H, br d, J 13.8 Hz), and 1.22-1.16 (1H, m). m/z (ES+) 553, 555 (M+1). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
475 mg (60%) | With potassium phosphate; In tetrahydrofuran; | EXAMPLE 144 1-(2,6-Dihydroxy-4-morpholin-4-yl-phenyl)-ethanone A solution of trifluoromethanesulfonic acid 4-acetyl-3,5-dihydroxy-phenyl ester (1.0 g, 3.33 mmol), morpholine (0.35 mL, 3.99 mmol), tris-(dibenzylideneacetone)dipalladium(0) (153 mg, 0.167 mmol), <strong>[224311-51-7]biphenyl-2-yl-di-tert-butyl-phosphane</strong> (198 mg, 0.666 mmol), and K3PO4 (1.41 mg, 6.66 mmol) in THF (2 mL) was heated to 85° C. in a sealed tube for 2 h. The reaction mixture was allowed to cool to room temperature, and filtered through a 3/4" silica gel (60 A) plug. The plug was washed with EtOAc (75 mL) and the filtrate concentrated. The concentrate was purified via Biotage chromatography with gradient elution from 100percent hexanes to 40percent EtOAc/hexanes to yield 475 mg (60percent) of 1-(2,6-dihydroxy-4-morpholin-4-yl-phenyl)-ethanone. Rf=0.16 (50percent EtOAc/hexanes). 1H NMR (CDCl3, 400 MHz) delta7.26 (s, 2H), 5.82 (s, 2H), 3.79 (c, 4H), 3.26 (m, 4H), 2.65 (s, 3H). LRMS (Electrospray, positive): Da/e 238.3 (m+1). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
269 mg (60%) | With sodium t-butanolate; In ethyl acetate; toluene; | REFERENCE EXAMPLE 85 1-(6-Chloro-3-pyridinyl)-4-ethylpiperazine A mixture of 5-bromo-2-chloropyridine (384 mg, 2.0 mmol), 1-ethylpiperazine (228 mg, 2.0 mmol), sodium tert-butoxide (576 mg, 6 mrnmol), tris(dibenzylideneacetone) dipalladium(0) (18.3 mg, 0.02 mmol), and 2-dicyclohexylphosphino-2'-(N,N-dimethylamino) biphenyl (23.6 mg, 0.06 mmol) in 10 mL of toluene was heated at reflux for 1 hour and concentrated. The residue was purified by flash column chromatography, eluding with 5% methanol in ethyl acetate to provide 269 mg (60%) of 1-(6-chloro-3-pyridinyl)-4-ethylpiperazine as a brown semi-solid: MS 225.9 (M+H) +. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
In toluene; | (a) N-Phenyl-4-piperidone. 1,4-Dioxa-8-azaspiro[4.5]-decane (2.0 g, 14.0 mmol, 1.0 equiv), Pd2(DBA)3 (0.31 g, 0.34 mmol, 0.024 equiv), BINAP (0.64 g, 1.0 mmol, 0.073 equiv), NaO-t-Bu (3.9 g, 41 mmol, 3.0 equiv) and bromobenzene (2.6 g, 17.7 mmol, 1.3 equiv) were combined under Ar in 50 mL of dry toluene. The resulting mixture was refluxed under Ar for 4 h. The reaction mix was cooled and poured into 250 mL of saturated sodium bicarbonate solution. The product was extracted with 3*100 mL CH2Cl2. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With potassium carbonate; In 1,2-dimethoxyethane; diethyl ether; water; pentane; | A. 4-[4-Isopropyl-piperazin-1-yl]-benzoic acid methyl ester Tris-(dibenzylidene-acetone)-dipalladium (0.05 mmol), (2'-dicyclohexylphosphanyl-biphenyl-2-yl)-dimethyl-amine (0.1 mmol) and potassium carbonate (4.6 mmol) are suspended in 1,2-dimethoxyethane (10 ml) in an oxygen-free atmosphere (N2). 4-Bromo-benzoic acid methyl ester (3.3 mmol) and 1-isopropyl-piperazine (3.9 mmol) are added and the stirred mixture is heated under reflux for 28 hours. After cooling the solvent is evaporated and water is added to the residue, which is then extracted three times with ethyl acetate. The combined extract is dried over sodium sulfate and evaporated. The residue is purified by flash chromatography on silica gel with (CH2Cl2/MeOH=95:5) as mobile phase. The product containing fractions are combined and evaporated. The residue is suspended in diethylether/pentane and the solid filtered of and dried (vacuum). A pale-brown powder with Rf=0.23 (CH2Cl2/MeOH=95:5) is obtained. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With sodium t-butanolate; In diethyl ether; ethyl acetate; toluene; | A. 4-(4-Benzyl-piperazin-1-yl)-benzoic acid methyl ester Tris-(dibenzylidene-acetone)-dipalladium (0.03 mmol), (2'-dicyclohexylphosphanyl-biphenyl-2-yl)-dimethyl-amine (0.9 mmol) and NaOtBu (6.5 mmol) are suspended in toluene (20 ml) in an oxygen-free atmosphere (N2). 4-Bromo-benzoic acid methyl ester (4.65 mmol) and 1-(benzyl)-piperazine (5.6 mmol) are added and the stirred mixture is heated under reflux for 4 hours. After cooling, a mixture of ethylacetate and diethylether is added and the mixture is filtered. Then the solvent is evaporated and the residue is suspended in diethylether and the solid filtered of and dried (vacuum). A pale powder with mp. 105-107 C., Rf=0.67 (CH2Cl2/MeOH=95:5) is obtained. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With NaH; In toluene; mineral oil; | Example 54H 4-benzyloxy-2-[7-(tert-butyl-dimethyl-silanyloxy)-naphthalen-1-ylamino]-benzoic Acid Benzyl Ester A mixture of benzyl-2-bromo-4-benzyloxybenzoate (285 mg, 0.717 mmol), 2-(tertbutyldimethylsilyloxy)-8-aminonaphthalene (196 mg, 0.717 mmol), tris-(dibenzylideneacetone)dipalladium (4 mg, 0.004 mmol), (2'-dicyclohexylphosphanyl-biphenyl-2-yl)-dimethyl-amine (6 mg, 0.015 mmol) and 60% NaH in mineral oil (45 mg, 1.1 mmol) in toluene (3 mL) was heated to reflux under N2 for 1 hour, poured into water (10 mL) acidified to a pH <3with aqueous 1M HCl and extracted with diethyl ether (3*5 mL). The combined ether layers were washed with brine (1*5 mL), dried (MgSO4), filtered, concentrated under reduced pressure and purified silica gel eluding with 10% ethyl acetate/hexanes to provide the titled compound. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
0.21 g (55%) | 5-Bromo-1H-pyrrole-2-carboxylic acid methyl ester (1.49 mmol, 0.30 g, prepared according to the procedure described in Method 4 of Example 2) in NMP (10 ml) was treated with triphenylarsine (0.30 mmol, 91 mg), tris(dibenzylideneacetone) dipalladium(0) (0.07 mmol, 68 mg), and 4-(trimethylstannyl)-isoquinoline (2.22 mmol, 0.65 g), then heated to reflux under an argon atmosphere overnight. The resulting mixture was concentrated under reduced pressure, then purified by silica gel chromatography to provide 0.21 g (55%) of 5-isoquinolin-4-yl-1H-pyrrole-2-carboxylic acid methyl ester. 1H NMR (CDCl3) delta9.81 (1H, br s), 9.35 (1H, s), 8.66 (1H, s), 8.31 (1H, d, J=8.5), 8.10 (1H, d, J=8.1), 7.91 (1H, t, J=15.2), 7.79 (1H, t, J 15.2), 7.11 (1H, dd, J=3.8, 2.5), 6.64 (1H, dd, J=3.7, 2.7), 3.90 (3H, s). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
95% | With phosphorous acid trimethyl ester;SiO2; In 1,4-dioxane; toluene; | Preparation 118 Preparation of 3-benzoyl-10-[2-(trifluoromethyl)phenyl]-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole 3-Benzoyl-10-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole (2.50 g, 6.00 mmol), triturated potassium phosphate (3.01 g, 14.2 mmol) and tris(dibenzylideneacetone) dipalladium(0) (0.562 g, 0.613 mmol) were combined in dioxane (63 mL) at rt under N2. 2-Bromobenzotrifluoride (0.98 mL, 1.62 g, 7.21 mmol) and trimethylphosphite (0.22 mL, 0.231 g, 1.86 mmol) were added to the reaction mixture by syringe. Ar was bubbled through the reaction mixture for 20 min. The reaction mixture was heated to reflux for 22 h. The reaction mixture was concentrated and the residue was taken up in toluene (150 mL) and H2O (200 mL). The layers were separated and the aqueous layer was extracted with toluene (1*100 mL, 1*50 mL). The combined organic layers were dried over MgSO4, filtered and concentrated. The crude product (3.90 g) was chromatographed (SiO2 250 g, eluted with 2:1 toluene:EtOAc) to yield 3-benzoyl-10-[2-(trifluoromethyl)phenyl]-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole (2.48 g) in 95% yield. IR (diffuse reflectance) 3294, 1617, 1575, 1461, 1439, 1423, 1346, 1334, 1316, 1276, 1266, 1259, 1178, 1170, 1126, 1113, 1105, 1058, 1034, 792, 775, 755, 719, 701, 626 cm-1; MS (ESI+) for C26H21F3N2O m/z 435.0 (M+H)+; Anal. Calcd for C26H21F3N2O: C, 71.88; H, 4.87; N, 6.45; found: C, 71.94; H, 4.93; N, 6.48. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
81% | With caesium carbonate; aniline; In 1,4-dioxane; toluene; | A. 2-(4-nitrophenyl)-6-(phenylamino)-2-hydroisoguinolin-1-one To a dry RBF under argon was added 6-bromo-2-(4-nitrophenyl)-2-hydroisoquinolin-1-one (66 mg, 0.191 mmol) (prepared as outlined in Example 1125), cesium carbonate (106 mg, 0.325 mmol), tris(dibenzylideneacetone) dipalladium(0) (3.5 mg, 0.076 mmol), 9,9-dimethyl-4,5-bis(diphenylphosphino) xanthene (12 mg, 0.0207 mmol) and neat aniline (0.026 mL, 0.285 mmol). To this flask was added dry dioxane (0.5 mL) and dry toluene (0.5 mL). The reaction was stirred at 80 C. for 5 hr, concentrated and chromatographed on silica gel to give pure 2-(4-nitrophenyl)-6-(phenylamino)-2-hydroisoquinolin-1-one (55 mg, 81%). ES-MS (M+H)+=358. |
81% | With caesium carbonate; aniline; In 1,4-dioxane; toluene; | A. 2-(4-nitrophenyl)-6-(phenylamino)-2-hydroisoguinolin-1-one To a dry RBF under argon was added 6-bromo-2-(4-nitrophenyl)-2-hydroisoquinolin-1-one (66 mg, 0.191 mmol) (prepared as outlined in Example 1125), cesium carbonate (106 mg, 0.325 mmol), tris(dibenzylideneacetone) dipalladium(0) (3.5 mg, 0.076 mmol), 9,9-dimethyl-4,5-bis(diphenylphosphino) xanthene (12 mg, 0.0207 mmol) and neat aniline (0.026 mL, 0.285 mmol). To this flask was added dry dioxane (0.5 mL) and dry toluene (0.5 mL). The reaction was stirred at 80 C. for 5 hr, concentrated and chromatographed on silica gel to give pure 2-(4-nitrophenyl)-6-(phenylamino)-2-hydroisoquinolin-1-one (55 mg, 81%). ES-MS (M+H)+=358. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
In 1,4-dioxane; dichloromethane; | To a suspension of <strong>[22282-75-3]3-fluoro-4-iodopyridine</strong> (2.23 g), 1-(tert-butoxycarbonyl)-4-(piperidin-4-ylcarbonyl)piperazine (1.49 g) and sodium t-butoxide (1.06 g) in 1,4-dioxan (20 ml) was added tris(dibenzylidene acetone)dipalladium(0) (0.09 g) and tri-o-tolylphosphine (0.12 g) and the mixture heated at reflux for 3 hours. The mixture was diluted with diethyl ether and washed with saturated aqueous sodium chloride solution, dried (Na2SO4) and evaporated. The residue was purified by chromatography on alumina (N32-63) eluding with 0.4percent methanol in dichloromethane to give as a solid, 1-(tert-butoxycarbonyl)-4-[1-(3-fluoro-4-pyridyl)piperidin-4-ylcarbonyl]piperazine (0.70 g). 1H-NMR (CDCl3): 1.45 (s, 9H), 1.80 (m, 2H), 2.00 (m, 2H), 2.65 (m, 1H), 2.90 (m, 2H), 3.40 (m, 8H), 3.80 (m, 2H), 6.70 (dd, 1H), 8.10 (d, 1H) and 8.20 (d, 1H); m/z 393 (M+1). | |
In 1,4-dioxane; dichloromethane; | To a suspension of <strong>[22282-75-3]3-fluoro-4-iodopyridine</strong> (2.23 g), 1-(tert-butoxycarbonyl)-4-(piperidin-4-ylcarbonyl) piperazine (1.49 g) and sodium t-butoxide (1.06 g) in 1,4-dioxan (20 ml) was added tris(dibenzylidene acetone)dipalladium(0) (0.09 g) and tri-o-tolylphosphine (0.12 g) and the mixture heated at reflux for 3 hours. The mixture was diluted with diethyl ether and washed with saturated aqueous sodium chloride solution. dried (Na2SO4) and evaporated. The residue was purified by chromatography on alumina (N32-63) eluding with 0.4percent methanol in dichloromethane to give as a solid, 1-(tert-butoxycarbonyl)-4-[1-(3-fluoro-4-pyridyl)piperidin-4-ylcarbonyl]piperazine (0.70 g). 1H-NMR (CDCl3): 1.45 (s, 9H), 1.80 (m, 2H), 2.00 (m, 2H), 2.65 (m, 1H), 2.90 (m, 2H), 3.40 (m, 8H), 3.80 (m, 2H), 6.70 (dd, 1H), 8.10 (d, 1H) and 8.20 (d, 1H); m/z 393 (M+1). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With hydrogenchloride; sodium carbonate; potassium carbonate;aluminium trichloride; In 1,2-dimethoxyethane; thionyl chloride; ethanol; dichloromethane; N,N-dimethyl-formamide; | Example 3 2-methoxy-7-pentoxyfluorenone <strong>[154607-00-8]Methyl 2-bromo-5-hydroxybenzoate</strong> (9.30 g, 40.26 mmol), 4-methoxyphenylboronic acid (6.54 g, 43.00 mmol), and tris(dibenzylideneacetone) dipalladium (0) (0.30 g, 0.33 mmol) were added to dimethoxyethane (75 mL) and 2M sodium carbonate (75 mL). The reaction mixture was stirred at reflux for 16 h then cooled and decanted and the residue washed with ethyl acetate. The combined organic layers were dried (MgSO4) and the solvent removed by rotary evaporation to afford 9.45 g of the coupled product (36.64 mmol, 91% yield). The coupled product (1.06 g, 4.10 mmol) was alkylated by treating it with pentyl iodide (1.16 g, 5.85 mmol) and potassium carbonate (1.38 g, 10.00 mmol) in DMF at 75 C. for 16 h. The cooled reaction mixture was partitioned between ethyl acetate and water. The solvent was removed from the combined organic layers by rotary evaporation to give the alkylated product. The alkylated product was hydrolyzed with 1N sodium hydroxide (10 mL) in refluxing ethanol (50 mL) until the TLC indicated that the saponification was complete. The cooled reaction mixture was acidified with 1N hydrochloric acid and extracted with methylene chloride. The organic layers were dried (MgSO4) and concentrated by rotary evaporation to give the acid. The acid was dissolved and warmed in thionyl chloride (50 mL) at 65 C. for 30 min. The solution was cooled to ambient temperature and the thionyl chloride was removed by rotary evaporation. The residue was dissolved in methylene chloride (50 mL) and aluminum chloride (0.67 g, 5.00 mmol) added. The reaction was stirred at ambient temperature for 2 h then quenched by adding the reaction mixture to a beaker containing 100 mL 1N hydrochloric acid and ice. The methylene chloride layer was separated and the acidic layer was washed with methylene chloride. The combined organic layers were dried (MgSO4) and the solvent removed by rotary evaporation to give 1.05 g of 2-methoxy-7-pentoxyfluorenone (3.55 mmol, 87% yield) as a red solid. 1 H NMR (300Mhz, CDCl3) delta 7.28 (d, J=8.3 Hz, 2H), 7.14 (s, 2H), 6.93 (d, J=8.3 Hz, 2H), 3.96 (q, J=7.5 Hz, 2H), 3.82 (s, 3H), 1.80 (p, J=7.6 Hz, 2H), 1.42 (m, 4H), 0.93 (t, J=7.5 Hz, 3H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With hydrogenchloride; In methanol; chloroform; water; N,N-dimethyl-formamide; toluene; | Example 70 <Synthesis of 1-(2-chloro-4-morpholinobenzyl)-2-methyl-6-((4-methylbenzene)sulfonylcarbamoyl)benzimidazole (70)> 1-(4-bromo-2-chlorobenzyl)-2-methyl-6-((4-methylbenzene)sulfonylcarbamoyl)benzimidazole (250 mg) was dissolved in 3 ml of toluene, to which 63 mg of sodium t-butyrate, 49 mg of morpholine, 2.2 mg of (R)-(+)-2,2'-bis(diphenylphosphino)-1,1'-binaphthyl, and 1.1 mg of tris(dibenzylideneacetone) dipalladium (0) were added in this order in a nitrogen atmosphere, and the solution was stirred at100°C for 20 hours. The reaction solution was concentrated under reduced pressure, and water was added thereto. Hydrochloric acid (1 N) was added to the solution to adjust to a pH of 7, and the solution was extracted with a mixture of chloroform and methanol at a ratio of 4:1. The organic layer was washed with saturated brine, dried with anhydrous magnesium sulfate, and then concentrated under reduced pressure. The residue was subjected to silica-gel column chromatography and eluted with a mixture of chloroform and methanol at a ratio of 30:1. The desired fractions were concentrated under reduced pressure. The residue was dissolved in 3.0 ml of N,N-dimethylformamide, and 3.2 ml of water was gradually added thereto in an oil bath at 80°C. The solution was allowed to cool. The crystals precipitated were collected through filtration, and dried under reduced pressure while being heated to give 103 mg of the title compound as pale yellow crystals. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
In 1,2-dimethoxyethane; hexane; ethyl acetate; | EXAMPLE 50 tert-Butyl (2E)-3-{6-cyano-7-[(2,4-dichloro-5-methoxyphenyl)amino]thieno[3,2-b]pyridin-2-yl}prop-2-enoate A mixture of tert-butyl (2E)-3-(7-chloro-6-cyanothieno[3,2-b]pyridin-2-yl)prop-2-enoate (1.29 g, 3.74 mmol), <strong>[98446-49-2]2,4-dichloro-5-methoxyaniline</strong> (862 mg, 4.49 mmol), Tris(dibenzylideneacetone)-dipalladium(0) (343 mg, 0.37 mmol), potassium phosphate (1.29 g, 5.61 mmol) and 2-dicyclohexylphosphino-2'-(N,N-dimethylamino)biphenyl (456 mg, 1.16 mmol) in 36 mL of ethylene glycol dimethyl ether is heated at 90 C. for 3 hours. The reaction mixture is cooled to room temperature and partitioned between water and ethyl acetate. The aqueous layer is extracted with additional ethyl acetate and the organic layers are combined, dried over sodium sulfate, filtered and concentrated in vacuo. The residue is purified by flash column chromatography eluding with a gradient of hexane to 40% ethyl acetate in hexane to provide 974 mg of tert-butyl (2E)-3-{6-cyano-7-[(2,4-dichloro-5-methoxyphenyl)amino]thieno[3,2-b]pyridin-2-yl}prop-2-enoate as a light tan solid, mp 224 C. dec; 1H NMR (DMSO-d6) delta 1.48 (s, 9H), 3.85 (s, 3H), 6.26 (d, J=16 Hz, 1H), 7.37 (s, 1H), 7.75 (d, J=16 Hz, 1H), 7.78 (s, 1H), 7.91 (s, 1H), 8.62 (s, 1H), 9.80 (s, 1H); MS 476.0, 478.0 (M+H)+. Analysis for C22H19Cl2N3O3S-0.4 H2O: Calcd: C, 54.64; H, 4.13; N, 8.69. Found: C, 54.51; H, 3.96; N, 8.50. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With tri-n-butyl-tin hydride; In ethyl acetate; N,N-dimethyl-formamide; | Example 1D ethyl 5-(3-((1E)-3-hydroxyprop-1-enyl)phenyl)isoxazole-3-carboxylate The tributyltin reagent from Example 1C (665 muL, 1.83 mmol) was added under nitrogen atmosphere to a mixture of alcohol from Example 1B (433 mg, 1.66 mmol), tris(dibenzylideneacetone)-dipalladium(0) (76 mg, 0.083 mmol), <strong>[5518-52-5]tri-2-furylphosphine</strong> (39 mg, 0.166 mmol), and cupper(I) iodide (32 mg, 0.166 mmol) in DMF (7 mL). The reaction mixture was stirred at ambient temperature for 30 minutes. Aqueous potassium fluoride was added to the mixture and the resulting suspension was filtered through celite and washed with ethyl acetate. The filtrate was taken up in ethyl acetate and water. The organic phase was washed with brine (*3), dried (MgSO4), filtered and concentrated under reduced pressure and purified by flash chromatography on silica gel with hexane/ethyl acetate (1:1) to provide the titled compound (353 mg). MS (ESI(+)) m/e 291 (M+18)+; 1H NMR (500 MHz, DMSO-d6) delta 8.05(t, J=1.7 Hz, 1H), 7.80 (dt, J1=1.7 Hz, J2=7.5 Hz, 1H), 7.60 (dt, J1=1.7 Hz, J2=7.5 Hz, 1H), 7.57 (s, 1H), 7.51(t, J=7.5 Hz, 1H), 6.63-6.59 (m, 2H), 4.94 (t, J=5.4 Hz, 1H), 4.41 (q, J=7.1 Hz, 2H), 4.19-4.14(m, 2H), 1.35 (t, J=7.1 Hz, 3H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With potassium carbonate; In ethyl acetate; tert-butyl alcohol; | Example 8A N-(2-Fluoro-4-nitrophenyl)-1H-pyrrolo[2,3-b]pyridine-4-amine A solution of 500 mg (3.28 mmol) of 4-chloro-1H-pyrrolo[2,3-b]pyridine (Schneller, Stewart, W.; Luo, Jiann-Kuan; J. Org. Chem. 1980, 45, 4045-4048.), 614 mg (3.93 mmol) of <strong>[369-35-7]2-fluoro-4-nitroaniline</strong>, 150 mg (0.16 mmol) of tris(dibenzylidenacetone)dipalladium and 156 mg (0.33 mmol) of dicyclohexyl(2',4',6'-triisopropylbiphenyl-2-yl)phosphine and 996 mg (7.21 mmol) of potassium carbonate in 5.00 ml of degassed tert-butanol is stirred in a sealed pressure vessel at 100 C. for 3 h. After cooling to RT, the mixture is filtered through Celite, the Celite is washed with ethyl acetate and the filtrates are concentrated under reduced pressure. The residue is purified by column chromatography on silica gel (mobile phase: cyclohexane/ethyl acetate 1:1). Yield: 694 mg (78% of theory) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With sodium t-butanolate; In ethyl acetate; toluene; | Example 27A N-(2-Fluoro-4-nitrophenyl)-3-methyl-1-[2-(trimethylsilyl)ethoxy]methyl}-1H-pyrrolo[2,3-b]pyridine-4-amine A solution of 29 mg (100 mumol) of 3-methyl-1-[2-(trimethylsilyl)ethoxy]methyl}-1H-pyrrolo[2,3-b]pyridine-4-amine, 33 mg (130 mumol) of <strong>[2996-30-7]2-fluoro-1-iodo-4-nitrobenzene</strong>, 5 mg (10 mumol) of tris-(dibenzylideneacetone)dipalladium, 6 mg (10 mmol) of 1,1'-bis(diphenylphosphino)ferrocene and 14 mg (150 mmol) of sodium tert-butoxide in 3 ml of degassed toluene is stirred at 100 C. overnight. After cooling to RT, the reaction mixture is directly applied to a silica gel column and separated (mobile phase: cyclohexane/ethyl acetate 10:1 to 8:2). Yield: 20 mg (46% of theory) LC-MS (Method 9): Rt=2.78 min. MS (ESI pos.): m/z=417 (M+H)+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With sodium t-butanolate; In ethyl acetate; toluene; | Example 36A N-(2-Fluoro-4-nitrophenyl)-<strong>[869335-48-8]1-methyl-1H-pyrrolo[2,3-b]pyridine-4-amine</strong> A solution of 260 mg (1.77 mmol) of <strong>[869335-48-8]1-methyl-1H-pyrrolo[2,3-b]pyridine-4-amine</strong>, 566 mg (2.12 mmol) of 2-fluoro-1-iodo-4-nitrobenzene, 81 mg (0.09 mmol) of tris(dibenzylidene-acetone)dipalladium, 98 mg (0.18 mmol) of 1,1'-bis(diphenylphosphino)ferrocene and 238 mg (2.47 mmol) of sodium tert-butoxide in 8 ml of degassed toluene is stirred at 100° C. overnight. After cooling to RT, the reaction mixture is applied directly to a silica gel column and separated (mobile phase: cyclohexane/ethyl acetate 10:1 to 1:1). Yield: 210 mg (42percent of theory) LC-MS (Method 8): Rt=1.89 min. MS (ESI pos.): m/z=287 (M+H)+. 1H-NMR (DMSO-d6, 300 MHz): delta=3.80 (s, 3H), 6.48 (d, 1H), 6.83 (d, 1H), 7.35 (dd, 1H), 7.40 (d, 1H), 8.03 (d, 1H), 8.13 (d, 1H), 8.18 (d, 1H), 9.32 (s, 1H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
In dichloromethane; water; ethyl acetate; toluene; | Example 5 Synthesis of Compound 5 Synthesis of N-(3,5-diisobutylbiphenyl-4-yl)benzamide. A mixture of N-(3,5-dibromobiphenyl-4-yl)benzamide (8.52 g, 19.8 mmol), isobutyl boronic acid (8.06 g, 79.2 mmol), potassium phosphate monohydrate (13.7 g, 59.4 mmol), water. (50 mL) and toluene (150 mL) was purged with nitrogen for 20 min before addition of tris(dibenzylideneacetone) dipalladium(0) (0.27 g 3% Pd) and 2-dicyclohexylphosphino-2',6'-dimethoxybiphenyl (0.49 g, 6 mol %). The reaction was stirred at reflux for 18 h. After cooling to ambient temperature the mixture was diluted with ethyl acetate and water. The layers were separated and the organic layer was concentrated and chromatographed on a silica gel column. Elution first with dichloromethane then dichloromethane and ethyl acetate (49:1) gave 6.53 g (86% yield) of the desired product as a solid. 1H NMR confirmed the structure. Synthesis of 1-(3,5-diisobutylbiphenyl-4-yl)-2-phenyl-1H-imidazole. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
735 mg (0.888 mmol, 88%) | In tetrahydrofuran; hexane; ethyl acetate; | Step A 9-{5-O-[bis(4-methoxyphenyl)(phenyl)methyl]-2-o-[4-(1,3-oxazol-2-yl)benzyl]-beta-D-ribofuranosyl}-6-[2-(trimethylsilyl)ethoxy]-9H-purine Tris[dibenzylideneacetone]dipalladium(0) (131 mg, 0.143 mmol) and <strong>[932710-63-9][4-(N,N-dimethylamino)phenyl]di-tert-butylphosphine</strong> (152 mg, 0.572 mmol) were added to THF (10 mL) at ambient temperature and stirred for 30 min. To this mixture was then added a solution of 9-{5-O-[bis(4-methoxyphenyl)(phenyl)methyl]-2-o-(4-bromobenzyl)-beta-D-ribofuranosyl}-6-[2-(trimethylsilyl)ethoxy]-9H-purine (Intermediate 3, 800 mg, 0.953 mmol) and 2-(tri-N-butylstannyl)oxazole (1.02 g, 2.86 mmol) in THF (15 mL). The mixture was heated at 50 C. and stirred for 16 h. After cooled to ambient temperature, the mixture was filtered through a layer of Celite. The filtrate was concentrated in vacuo. The residue was purified with flash chromatography using 55-60% ethyl acetate in hexane to obtain 735 mg (0.888 mmol, 88%) of the pure product. LCMS: for C46H49N5O8Si calculated 828.0. found 828.3 [M+H]+. 1H NMR (600 MHz, CD3CN) delta: 8.22 (s, 1H), 8.05 (s, 1H), 7.88 (s, 1H), 7.77 (d, J=8.2 Hz, 2H), 7.41 (d, J=8.0 Hz, 2H), 7.25 (m, 7H), 6.80 (m, 4H), 6.09, (d, J=5.5 Hz, 1H), 4.78 (m, 2H), 4.58 (m, 4H), 4.19 (dd, J=8.4, 4.3 Hz, 1H), 3.76 (s, 6H), 3.59 (d, J=5.2 Hz, 2H), 3.33 (d, J=4.5 Hz, 2H), 1.21 (m, 2H), 0.10 (s, 9H). 13C NMR (600 MHz, CD3CN) delta: 158.82, 151.74, 145.21, 141.78, 140.29, 139.61, 136.05, 136.00, 130.21, 130.17, 128.58, 128.40, 128.18, 127.98, 127.00, 126.00, 117.54, 117.07, 113.19, 87.14, 86.34, 84.55, 80.02, 71.85, 69.98, 65.20, 63.53, 55.08, 17.18, -2.13. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With ammonium chloride; triphenylphosphine; In tetrahydrofuran; 1,4-dioxane; ethyl acetate; | Intermediate 8 5-(1-Allyloxypent-4-enyl)-<strong>[3994-50-1]1-methyl-4-nitro-pyrazole</strong> To a solution of <strong>[3994-50-1]1-methyl-4-nitro-pyrazole</strong> (9.7 g, 76.7 mmol) and pent-4-enal (10.0 g, 84.4 mmol) in THF (250 mL) at -78 C. was added dropwise a solution of LiHMDS in THF (1 M, 192 mL, 191.7 mmol). The reaction mixture was allowed to warm to -40 C. and stirred for 4 hr. The reaction was quenched with a saturated solution of ammonium chloride (100 mL), warmed to room temperature and the solvents removed under reduced pressure. The residue was dissolved in EtOAc (100 mL) and washed with water (30 mL). The organic layer was separated, dried over MgSO4 and concentrated under reduced pressure. Purification via silica gel column chromatography (0-30% EtOAc/isohexane) gave a clear oil. This oil (7.1 g, 33.6 mmol), diallyl carbonate (14.33 g, 100.9 mmol) and triphenylphosphine (880 mg, 3.35 mmol) were dissolved in dioxane (236 mL) under nitrogen before tris(dibenzylideneacetone)-dipalladium(0) (780 mg, 0.84 mmol) was added. The reaction mixture was heated at 50 C. for 1 hr and the solvent removed under reduced pressure. Purification via silica gel column chromatography (0-40% EtOAc/isohexane) gave 5-(1-allyloxypent-4-enyl)-<strong>[3994-50-1]1-methyl-4-nitro-pyrazole</strong> as a yellow oil (8.35 g, 43% over two steps). 1H NMR (400 MHz, CDCl3) delta 8.06 (s, 1H), 5.90-5.73 (m, 2H), 5.46 (dd, J=8.8, 5.1 Hz, 1H), 5.29-5.16 (m, 2H), 5.10-5.00 (m, 2H), 4.04 (s, 3H), 3.92 (d, J=5.8 Hz, 2H), 2.37-2.25 (m, 1H), 2.22-2.09 (m, 1H), 2.09-1.96 (m, 1H), 1.84 (dddd, J=13.7, 9.2, 6.9, 5.1 Hz, 1H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
76% | Step 1: Synthesis of 5-chloro-3-methylpicolinonitrile A mixture of <strong>[65550-77-8]2-bromo-5-chloro-3-methylpyridine</strong> (45 g, 218 mmol), zinc cyanide (8.30 mL, 131 mmol), tris(dibenzylideneacetone)dipalladium (0) (4.99 g, 5.45 mmol), and 1,1'-bis(diphenylphosphino)ferrocene (6.04 g, 10.90 mmol) in dimethylacetamide (40 mL) was heated to 110 C. for 4 hours. The reaction mixture was cooled to RT, diluted with water and extracted with ethyl acetate. The organic phase obtained was concentrated under reduced pressure and residue purified by chromatography on silica gel using ISCO eluting with 0-60% EtOAc/hex to afford the title compound 5-chloro-3-methylpicolinonitrile (25.4 g, 166 mmol, 76% yield). LC/MS (ESI+) m/z=153.1 (M+H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With potassium acetate; In diethyl ether; water; acetonitrile; | Step 1: Preparation of intermediate (2,3-dihydropyrano[4,3,2-de]quinolin-7-yl)-boronic acid (3a) A vial containing the 7-bromo-2,3-dihydro-1-oxa-6-aza-phenalene (600 mg, 2.40 mmol, prepared according to ), tris(dibenzylidene acetone)dipalladium(0) (22 mg, 0.024 mmol), di(1-adamantyl)-n-butylphosphine (25.8 mg, 0.072 mmol), bis[pinacolato]diboron (731 mg, 2.88 mmol) and potassium acetate (706 mg, 7.20 mmol) was purged with argon for 10 minutes and then degassed anhydrous dimethylacetamide (2 mL) was added. The resulting mixture was stirred at 90C for 4 hours. The mixture was cooled to room temperature and water was added slowly (40 mL). The precipitate was filtered, washed with water (20 mL) and toluene (10 mL), dried in vacuo and triturated in diethyl ether. The powder was dissolved in acetonitrile and the solution was then filtered on Millipore and the filtrate concentrated in vacuo to provide (2,3-dihydropyrano[4,3,2-de]quinolin-7-yl)-boronic acid (3a) (301 mg, 1.39 mmol, 58%). 1H NMR (400 MHz, DMSO-d6 + D2O) d 3.27 (t, 2H, J = 5.8 Hz), 4.44 (t, 2H, J = 5.8 Hz), 7.03 (d, J = 7.8 Hz, 1 H), 7.35 (d, J = 4.5 Hz, 1 H), 8.16 (d, J = 7.8 Hz, 1 H), 8.83 (d, J = 4.5 Hz, 1 H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
3rd step: (4-[9,9'-bianthracen-10-yl]phenyl)diphenylphosphine oxide (4-(10-bromoanthracen-9-yl)phenyl)diphenyl phosphine oxide (5.0 g, 9.4 mmol, 1.0 eq), 9-anthracene boronic acid (3.12 g, 14.1 mmol, 1.5 eq), tris(dibenzylidenaceton)dipalladium(0) (172 mg, 0.19 mmol, 4.0 mol. %), dicyclohexyl(2',6'-dimethoxy-[1,1'-biphenyl]-2-yl)phosphine (308 mg, 0.75 mmol, 8.0 mol. %) and potassium phosphate (5.97 g, 28.1 mmol, 3.0 eq), were placed in a flask and suspended in toluene (20 mL). The resulting mixture was heated at 120 C. for 48 h. After cooling to RT, DCM and water were added; the organic phase was decanted and extracted with water until the aqueous was neutral. The aqueous layers were also extracted with ethyl acetate (2*200 mL) and decanted. The combined organic layers were extracted with an aqueous sodium diethylcarbamodithioate solution, decanted, dried over MgSO4, and evaporated to dryness. The crude product was then re-crystallized from 1,4-dioxane, and finally sublimed under reduced pressure. HPLC purity: 99.18% 1H NMR (CDCl3, 25 C.): delta=8.75 (s, 1H); 8.20 (d, J=8.6 Hz, 2H); 7.97 (dd, J=8.0, 11.7 Hz, 2H); 7.87 (m, 4H); 7.77 (m, 4H); 7.65 (m, 2H); 7.59 (m, 4H); 7.48 (m, 2H); 7.35 (m, 2H); 7.16 (m, 8H) ppm. 13C NMR (CDCl3, 25 C.): delta=143.62; 143.60; 137.12; 134.33; 134.05; 133.49; 133.22; 132.67; 132.56; 132.21; 131.77; 130.43; 129.27; 129.17; 127.98; 127.46; 127.41; 127.13; 126.51; 126.20; 126.14; 125.97 ppm |
Tags: 52409-22-0 synthesis path| 52409-22-0 SDS| 52409-22-0 COA| 52409-22-0 purity| 52409-22-0 application| 52409-22-0 NMR| 52409-22-0 COA| 52409-22-0 structure
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :